In order to clarify whether MDM2-induced Osimertinib resistance follows this dogma, we treated NSCLC cells with increasing concentrations of Osimertinib and determined the phosphorylation state of Akt and Erk. Here, AKT1 is linked to non-small cell lung carcinoma.